Scott Kogan
Overview
Explore the profile of Scott Kogan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Francis S, Wallace A, Wendt G, Li L, Liu F, Riley L, et al.
Blood
. 2016 Dec;
129(12):1680-1684.
PMID: 27979823
It is widely suspected, yet controversial, that infection plays an etiologic role in the development of acute lymphoblastic leukemia (ALL), the most common childhood cancer and a disease with a...
12.
Meyer S, Qin T, Muench D, Masuda K, Venkatasubramanian M, Orr E, et al.
Cancer Discov
. 2016 Mar;
6(5):501-15.
PMID: 27016502
Unlabelled: Cytogenetically normal acute myeloid leukemia (CN-AML) represents nearly 50% of human AML. Co-occurring mutations in the de novo DNA methyltransferase DNMT3A and the FMS related tyrosine kinase 3 (FLT3)...
13.
Chang T, Krisman K, Theobald E, Xu J, Akutagawa J, Lauchle J, et al.
J Clin Invest
. 2016 Jan;
126(1):404.
PMID: 26727232
No abstract available.
14.
Chen C, Liu Y, Rappaport A, Kitzing T, Schultz N, Zhao Z, et al.
Cancer Cell
. 2014 May;
25(5):652-65.
PMID: 24794707
Recurring deletions of chromosome 7 and 7q [-7/del(7q)] occur in myelodysplastic syndromes and acute myeloid leukemia (AML) and are associated with poor prognosis. However, the identity of functionally relevant tumor...
15.
Chang T, Krisman K, Theobald E, Xu J, Akutagawa J, Lauchle J, et al.
J Clin Invest
. 2012 Dec;
123(1):335-9.
PMID: 23221337
Children with neurofibromatosis type 1 (NF1) are predisposed to juvenile myelomonocytic leukemia (JMML), an aggressive myeloproliferative neoplasm (MPN) that is refractory to conventional chemotherapy. Conditional inactivation of the Nf1 tumor...
16.
Choi G, Huang B, Pinarbasi E, Braunstein S, Horvai A, Kogan S, et al.
Cancer Res
. 2012 Oct;
72(24):6425-34.
PMID: 23071067
Second malignant neoplasms (SMN) are therapy-induced malignancies and a growing problem in cancer survivors, particularly survivors of childhood cancers. The lack of experimental models of SMNs has limited understanding of...
17.
Wang X, Takagawa J, Lam V, Haddad D, Tobler D, Mok P, et al.
Sci Transl Med
. 2011 Sep;
3(100):100ra90.
PMID: 21918107
Delivery of bone marrow cells (BMCs) to the heart has substantially improved cardiac function in most rodent models of myocardial infarction (MI), but clinical trials of BMC therapy have led...
18.
Viatour P, Somervaille T, Venkatasubrahmanyam S, Kogan S, McLaughlin M, Weissman I, et al.
Cell Stem Cell
. 2008 Oct;
3(4):416-28.
PMID: 18940733
Individual members of the retinoblastoma (Rb) tumor suppressor gene family serve critical roles in the control of cellular proliferation and differentiation, but the extent of their contributions is masked by...
19.
Omidvar N, Kogan S, Beurlet S, Le Pogam C, Janin A, West R, et al.
Cancer Res
. 2007 Dec;
67(24):11657-67.
PMID: 18089795
Myelodysplastic syndromes (MDS) are clonal stem cell hematologic disorders that evolve to acute myeloid leukemia (AML) and thus model multistep leukemogenesis. Activating RAS mutations and overexpression of BCL-2 are prognostic...
20.
Forsberg E, Serwold T, Kogan S, Weissman I, Passegue E
Cell
. 2006 Jul;
126(2):415-26.
PMID: 16873070
A model of hematopoietic development wherein multipotentiality is conserved until segregation of myeloid and lymphoid potential has recently been challenged, proposing that megakaryocyte/erythrocyte (MegE) potential is lost in Flk2/Flt3-expressing early...